Cargando…

Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study

OBJECTIVE: T cell immunoglobulin and mucin domain-3 (Tim-3) may be implicated in neuroinflammation. Herein, we attempted to discern the role of serum soluble (s) Tim-3 as an inflammatory prognostic biomarker of severe traumatic brain injury (sTBI). METHODS: In this prospective observational study of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Han, Lv, Qing-Wei, Zheng, Zi-Qiang, Shen, Liang-Jun, Zhou, Jing, Guo, Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868801/
https://www.ncbi.nlm.nih.gov/pubmed/36698699
http://dx.doi.org/10.2147/NDT.S396771
_version_ 1784876624905240576
author Zhang, Han
Lv, Qing-Wei
Zheng, Zi-Qiang
Shen, Liang-Jun
Zhou, Jing
Guo, Mi
author_facet Zhang, Han
Lv, Qing-Wei
Zheng, Zi-Qiang
Shen, Liang-Jun
Zhou, Jing
Guo, Mi
author_sort Zhang, Han
collection PubMed
description OBJECTIVE: T cell immunoglobulin and mucin domain-3 (Tim-3) may be implicated in neuroinflammation. Herein, we attempted to discern the role of serum soluble (s) Tim-3 as an inflammatory prognostic biomarker of severe traumatic brain injury (sTBI). METHODS: In this prospective observational study of 112 sTBI patients and 112 controls, serum sTim-3 levels were determined, Rotterdam computed tomography (CT) classification and Glasgow coma scale (GCS) were selected as the two severity indicators, serum C-reactive protein (CRP) was regarded as an inflammatory biomarker, and poor prognosis was referred to as extended Glasgow outcome scale (GOSE) scores 1–4 at 180 days after trauma. RESULTS: Serum sTim-3 levels were markedly higher in patients than in controls (median, 4.2 ng/mL versus 0.7 ng/mL; P<0.001). Serum sTim-3 levels of patients were independently related to Rotterdam CT scores (β=1.126), GCS scores (β=−0.589), serum CRP levels (β=0.155) and GOSE scores (β=−0.211). Serum sTim-3 appeared as an independent predictor of post-traumatic 180-day mortality (odds ratio=1.289), overall survival (hazard ratio=1.208) and poor prognosis (odds ratio=1.293). Serum sTim-3 levels discriminated patients at risk of post-injury 180-day mortality and poor prognosis with areas under curve (AUCs) at 0.753 and 0.782, respectively. Serum sTim-3 levels combined with GCS scores and Rotterdam CT scores (AUC=0.869) exhibited significantly higher AUC than Rotterdam CT scores (P=0.026), but not than GCS scores (P=0.181) for death prediction and their combination (AUC=0.895) had significantly higher AUC than GCS scores (P=0.036) or Rotterdam CT scores (P=0.005) for outcome prediction. CONCLUSION: Elevated serum sTim-3 levels, in close correlation with traumatic severity and inflammation, are substantially associated with long-term death and poor outcome, indicating that serum sTim-3, as an inflammatory biomarker, may be of clinical significance in severity assessment and prediction of prognosis following sTBI.
format Online
Article
Text
id pubmed-9868801
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98688012023-01-24 Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study Zhang, Han Lv, Qing-Wei Zheng, Zi-Qiang Shen, Liang-Jun Zhou, Jing Guo, Mi Neuropsychiatr Dis Treat Original Research OBJECTIVE: T cell immunoglobulin and mucin domain-3 (Tim-3) may be implicated in neuroinflammation. Herein, we attempted to discern the role of serum soluble (s) Tim-3 as an inflammatory prognostic biomarker of severe traumatic brain injury (sTBI). METHODS: In this prospective observational study of 112 sTBI patients and 112 controls, serum sTim-3 levels were determined, Rotterdam computed tomography (CT) classification and Glasgow coma scale (GCS) were selected as the two severity indicators, serum C-reactive protein (CRP) was regarded as an inflammatory biomarker, and poor prognosis was referred to as extended Glasgow outcome scale (GOSE) scores 1–4 at 180 days after trauma. RESULTS: Serum sTim-3 levels were markedly higher in patients than in controls (median, 4.2 ng/mL versus 0.7 ng/mL; P<0.001). Serum sTim-3 levels of patients were independently related to Rotterdam CT scores (β=1.126), GCS scores (β=−0.589), serum CRP levels (β=0.155) and GOSE scores (β=−0.211). Serum sTim-3 appeared as an independent predictor of post-traumatic 180-day mortality (odds ratio=1.289), overall survival (hazard ratio=1.208) and poor prognosis (odds ratio=1.293). Serum sTim-3 levels discriminated patients at risk of post-injury 180-day mortality and poor prognosis with areas under curve (AUCs) at 0.753 and 0.782, respectively. Serum sTim-3 levels combined with GCS scores and Rotterdam CT scores (AUC=0.869) exhibited significantly higher AUC than Rotterdam CT scores (P=0.026), but not than GCS scores (P=0.181) for death prediction and their combination (AUC=0.895) had significantly higher AUC than GCS scores (P=0.036) or Rotterdam CT scores (P=0.005) for outcome prediction. CONCLUSION: Elevated serum sTim-3 levels, in close correlation with traumatic severity and inflammation, are substantially associated with long-term death and poor outcome, indicating that serum sTim-3, as an inflammatory biomarker, may be of clinical significance in severity assessment and prediction of prognosis following sTBI. Dove 2023-01-18 /pmc/articles/PMC9868801/ /pubmed/36698699 http://dx.doi.org/10.2147/NDT.S396771 Text en © 2023 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Han
Lv, Qing-Wei
Zheng, Zi-Qiang
Shen, Liang-Jun
Zhou, Jing
Guo, Mi
Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study
title Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study
title_full Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study
title_fullStr Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study
title_full_unstemmed Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study
title_short Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study
title_sort prognostic role of serum soluble tim-3 in severe traumatic brain injury: a prospective observational study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868801/
https://www.ncbi.nlm.nih.gov/pubmed/36698699
http://dx.doi.org/10.2147/NDT.S396771
work_keys_str_mv AT zhanghan prognosticroleofserumsolubletim3inseveretraumaticbraininjuryaprospectiveobservationalstudy
AT lvqingwei prognosticroleofserumsolubletim3inseveretraumaticbraininjuryaprospectiveobservationalstudy
AT zhengziqiang prognosticroleofserumsolubletim3inseveretraumaticbraininjuryaprospectiveobservationalstudy
AT shenliangjun prognosticroleofserumsolubletim3inseveretraumaticbraininjuryaprospectiveobservationalstudy
AT zhoujing prognosticroleofserumsolubletim3inseveretraumaticbraininjuryaprospectiveobservationalstudy
AT guomi prognosticroleofserumsolubletim3inseveretraumaticbraininjuryaprospectiveobservationalstudy